| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
1.94 0.01 (0.01%) |
08-21 16:00 |
|
Open: |
1.95 |
Pre close: |
1.93 |
Target:
|
2.64 
|
|
High: |
1.97 |
Low: |
1.91 |
Resistance:
|
2.26
2.50
|
|
Volume: |
846,925 |
Market Cap: |
324M |
Support:
|
1.87
1.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.94
|
MACD |
MACD(12,26):
|
-0.11 |
|
MA(20): |
2.12 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
2.27 |
Stochastic Oscillator |
%K(14,3):
|
16.61  |
|
MA(250): |
2.51 |
%D(3): |
15.39 |
|
Average Volume(K) |
3-Month: |
115169
|
52-Week |
High:
|
3.65 |
|
10-Days: |
112159 |
Low: |
1.87 |
|
RSI |
RSI(14):
|
33.48 |
Change(%): |
-31.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.385 |
Return on Equity (ttm) |
-72.7 |
Shares Out. (M) |
167.19 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-30.5 |
Shares Float (M) |
166.71 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.10 |
% Held by Insiders |
0.25 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
97.74 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
-0.016 |
Shares Short (K) |
14770 |
|
Book Value (p.s.) |
0.570 |
EBITDA (p.s.) |
-0.393 |
P/E |
-5.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.40 |
|
Profit Margin |
-111.48 |
Operating Cash Flow
(M) |
-36.00 |
P/S |
953966528.00 |
|
Operating Margin |
-116.09 |
Levered Free Cash Flow
(M) |
-41.46 |
P/CF |
-9.01 |
|
|
|
|
|
|
